personally, I think SAVA is overpriced, but not as much as when it was wildly overpriced by the kids who were buying it at 120 or 130 or 140, but then again, I think the entire market is wildly overpriced still.
One might also consider it this way: Wall sTreet will never let a stock go from 6 bucks to 140 without being in the stock, and guess what, wall street was not in the stock. Not at 70 or 90 or 110 or 140.....Wall street wants to own twice as many of the shares as it now does, but at 25 bucks a share, and even lower. So they do this short attack thing, for starters.
consider Bitcoin, which went from 800 to 20,000, with kid investors from all over the world. In 2014 and 2015, when it hit its highs, you could turn on the TV and all you would hear (or read) is that Bitcoin was a fad, people were gonna be destroyed, it had more problems than a person with leprosy. After repeating this ten million times, they brought it down, an information war, back to 2800, and then for a year and a half, wall street loaded up.
Now wall street is in bitcoin, and it is a tremendous thing...they loadded the boat from 3000 to 15,000 and now half of wall street, which is all you need, is so into bitcoin you cannot believe it.....how did these people get so darn smart in just two years?
SAVA has its main product with 1 750 person test to go, which will take almost 3 years, to get a readout; it is possible it could come sooner for sure. But I cannot see even under an expedited pathway how SAVA can gt approved within 2 years, and that is the very earliest. FDA is corrupt and no way will they let this happen to Big Pharma, who they sort of have adopted in this area. For little areas, that is a different story, where there are much smaller companies competing for a much smaller annual market, say in the 200 to 500 million dollar range. But in this market, which might be 10 to 20X larger, there is no way Big Pharma will let a tiny company get the market. That will never happen. The FDA is riddled with corruption. They will not hurrry a product along, even if it save 3 million lives per year, unless Big Pharma owns the product. They will of course, hurry deadly dangerous unapproved and horrid vac products along, but that just makes my point, as did the BIIB recent approval. Corruption is all over this agency, as it is all of the fed agencies.
So I think for these reasons SAVA is still way overpriced. It can easily see mid 30s, and if the market gets real, 20s for sure. If the market undergoes a slow moving bear market, which I can see kicking off at some point, SAVA is back to the teens.
